Brief: Spectrum Pharmaceuticals Announces Strategic Restructuring
05/01/2022 13:32
Jan 5 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS ANNOUNCES STRATEGIC RESTRUCTURING
* SPECTRUM PHARMACEUTICALS INC - WORKFORCE REDUCTION OF
APPROXIMATELY 30%
* SPECTRUM PHARMACEUTICALS INC - CASH RUNWAY EXTENDED INTO
2023
* SPECTRUM PHARMACEUTICALS INC - RESOURCES TO BE FOCUSED ON
LATE-STAGE ASSETS, POZIOTINIB AND ROLONTIS
* SPECTRUM PHARMACEUTICALS INC - PHYSICAL FOOTPRINT OF
SELECTED
FACILITIES WILL BE SIGNIFICANTLY REDUCED IN 2022
Source text for Eikon: ID:nBw7DG5D6a
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary